tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
:PSTV
US Market
Advertisement

Plus Therapeutics (PSTV) Technical Analysis

Compare
1,009 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Plus Therapeutics’s (PSTV) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Plus Therapeutics is a Sell.
Plus Therapeutics’s (PSTV) 20-Day exponential moving average is 0.49, while Plus Therapeutics’s (PSTV) share price is $0.66, making it a Buy.
Plus Therapeutics’s (PSTV) 50-Day exponential moving average is 0.46, while Plus Therapeutics’s (PSTV) share price is $0.66, making it a Buy.

Plus Therapeutics (PSTV) Pivot Points

Aug 08, 2025, 07:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.43
0.50
0.62
0.69
0.81
0.88
1.00
Fibonacci
0.50
0.57
0.62
0.69
0.76
0.81
0.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Plus Therapeutics (PSTV) Moving Averages

Aug 08, 2025, 07:01 AM
Period
Simple
Exponential
MA5
0.58Buy
0.62Buy
MA10
0.57Buy
0.56Buy
MA20
0.46Buy
0.49Buy
MA50
0.37Buy
0.46Buy
MA100
0.57Buy
0.58Buy
MA200
0.89Sell
0.85Sell
Plus Therapeutics’s (PSTV) 10-Day exponential moving average is 0.56, while Plus Therapeutics’s (PSTV) share price is $0.66, making it a Buy.
Plus Therapeutics’s (PSTV) 100-Day exponential moving average is 0.58, while Plus Therapeutics’s (PSTV) share price is $0.66, making it a Buy.
Plus Therapeutics’s (PSTV) stock price is $0.66 and Plus Therapeutics’s (PSTV) 50-day simple moving average is 0.37, creating a Buy signal.
Plus Therapeutics’s (PSTV) stock price is $0.66 and Plus Therapeutics’s (PSTV) 100-day simple moving average is 0.57, creating a Buy signal.
Plus Therapeutics’s (PSTV) stock price is $0.66 and Plus Therapeutics’s (PSTV) 200-day simple moving average is 0.89, creating a Sell signal.

Plus Therapeutics (PSTV) Technical Indicators

Aug 08, 2025, 07:01 AM
Name
Value
Implied Action
RSI (14)
63.63
Neutral
STOCH (9,6)
67.89
Neutral
STOCHRSI (14)
73.82
Neutral
MACD (12,26)
0.07
Sell
ADX (14)
37.15
Neutral
Williams %R
-41.74
Buy
CCI (14)
161.83
Sell
ATR (14)
0.10
-
Ultimate Oscillator
46.36
Neutral
ROC
106.25
Buy
Plus Therapeutics’s (PSTV) Relative Strength Index (RSI) is 63.63, creating a Neutral signal.
Plus Therapeutics’s (PSTV) Trend Strength Indicator (ADX) is 37.15, creating a Neutral signal.
Plus Therapeutics’s (PSTV) Commodity Channel Index (CCI) is 161.83, creating a Sell signal.
Plus Therapeutics’s (PSTV) Price Rate of Change (ROC) is 106.25, creating a Buy signal.

FAQ

Is PSTV a Buy, Hold, or Sell?
Based on PSTV’s technical indicators, PSTV is a Buy.
    What is PSTV’s RSI (14)?
    PSTV’s RSI (14) is 63.63, which suggests PSTV is a Neutral.
      What is PSTV’s MACD?
      PSTV’s MACD is 0.07, which suggests PSTV is a Sell.
        What is PSTV’s 5-day moving average?
        PSTV’s 5-day moving average is 0.58, which suggests PSTV is a Buy.
          What is PSTV’s 20-day moving average?
          PSTV 20-day moving average is 0.46, which suggests PSTV is a Buy.
            What is PSTV’s 50-day moving average?
            PSTV’s 50-day moving average is 0.37, which suggests PSTV is a Buy.
              What is PSTV’s 200-day moving average?
              PSTV’s 200-day moving average is 0.89, which suggests PSTV is a Sell.
                What is PSTV’s Williams % R (14)?
                PSTV’s Williams % R (14) is -41.74, which suggests PSTV is a Buy.
                  What is PSTV’s CCI (14)?
                  PSTV’s CCI (14) is 161.83, which suggests PSTV is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis